References
- Howard P, Pulcini C, Nathwani D, Levy-Hara G, Gould I. Development of a Worldwide Antimicrobial Stewardship Survey. Presented at: 22nd European Congress of Clinical Microbiology and Infectious Diseases (ECCMID). London, UK, 31 March–3 April 2012 (Poster 1059).
- Cook PP, Rizzo S, Gooch M, Jordan M, Fang X, Hudson S. Sustained reduction in antimicrobial use and decrease in methicillin-resistant Staphylococcus aureus and Clostridium difficile infections following implementation of an electronic medical record at a tertiary-care teaching hospital. J. Antimicrob. Chemother. 66(1), 205–209 (2011).
- Wickens HJ, Ashiru-Oredope DAI, Farrell S, Jacklin A, Holmes A. Managing and reporting of antibiotic usage data in English hospitals. Clin. Microbiol. Infect. 18(Suppl. S3), 108(O658) (2012).
- Dumartin C, Rogues A-M, L’Heriteau F et al. Antibiotic policies in 36 French intensive care units in 2010: which measures to control consumption? Clin. Microbiol. Infect. 18(Suppl. S3), 109(O659) (2012).
- Vaghela T, Parida S, Singh P. Optimising antimicrobial use: outcome of IV antimicrobial rounds as part of an Antimicrobial Stewardship Programme at a large district general hospital in east of England. Clin. Microbiol. Infect. 18(Suppl. S3), 107(O656) (2012).
- Fleet E, Gopal Rao G, Patel B et al. Randomised control study of antibiotic use in nursing/care homes: initial findings. Clin. Microbiol. Infect. 18(Suppl. S3), 109(O660) (2012).
- Martin M, Murillas J, Campins A et al. Adherence to recommendations of an Antimicrobial Stewardship Programme. Presented at: 22nd European Congress of Clinical Microbiology and Infectious Diseases (ECCMID). London, UK, 31 March–3 April 2012 (Poster 1054).
- Katsarolis I, Antoniadou A, Poulakou G et al. Antibiotic prescribing habits in primary care adult respiratory tract infections. Clin. Microbiol. Infect. 18(Suppl. S3), 41(O281) (2012).
- Denes E, Prouzergue J, Ducroix-Roubertou S, Aupetit C, Weinbreck P. Analysis of antibiotic prescriptions done by general practitioners for urinary tract infections. Clin. Microbiol. Infect. 18(Suppl. S3), 41(O283) (2012).
- Cortoos PJ, Bochet M, Horbarth S, Gyssens IC. The possible effect of sickness regulation on volume of antibiotic consumption in 30 European countries. Clin. Microbiol. Infect. 18(Suppl. S3), 41(O282) (2012).
- Cantón R, Bryan J. Global antimicrobial resistance: from surveillance to stewardship. Part 1: Surveillance. Expert Rev. Anti Infec. Ther. 10(11), 1269–1271 (2012).
- Ishii Y, Eto M, Mano Y, Tateda K, Yamaguchi K. In vitro potentiation of carbapenems with ME1071, a novel metallo-β-lactamase inhibitor, against metallo-β-lactamase-producing Pseudomonas aeruginosa clinical isolates. Antimicrob. Agents Chemother. 54(9), 3625–3629 (2010).
- Zhanel GG, Lawson CD, Zelenitsky S et al. Comparison of the next-generation aminoglycoside plazomicin to gentamicin, tobramycin and amikacin. Expert Rev. Anti. Infect. Ther. 10(4), 459–473 (2012).
- Grossman TH, Starosta AL, Fyfe C et al. Target- and resistance-based mechanistic studies with TP-434, a novel fluorocycline antibiotic. Antimicrob. Agents Chemother. 56(5), 2559–2564 (2012).